Edition:
United States

Winsan Shanghai Medical Science and Technology Co Ltd (600767.SS)

600767.SS on Shanghai Stock Exchange

12.82CNY
2:59am EDT
Change (% chg)

¥0.02 (+0.16%)
Prev Close
¥12.80
Open
¥12.78
Day's High
¥12.89
Day's Low
¥12.63
Volume
5,032,561
Avg. Vol
8,395,070
52-wk High
¥18.72
52-wk Low
¥11.80

Latest Key Developments (Source: Significant Developments)

Winsan Shanghai Medical Science and Technology says shareholding changes
Thursday, 13 Oct 2016 04:59am EDT 

Winsan Shanghai Medical Science and Technology Co Ltd <600767.SS>: Says a Shanghai-based investment group firm has transferred 50 million shares of the co to a Sichuan-based asset management firm .Says the Sichuan-based asset management firm holds 14.7 percent stake (50 million shares) in the co after transaction.  Full Article

Winsan Shanghai Medical Science and Technology says unfreeze of 15.7 pct stake shares
Friday, 23 Sep 2016 03:20am EDT 

Winsan Shanghai Medical Science and Technology <600767.SS>:Says 53,508,343 shares, or a 15.7 percent stake held by Shanghai Jiuchuan Investment Limited Company were unfrozen by Shanghai Pudong New Area People's Court.  Full Article

Winsan Shanghai Medical Science and Technology says unfreeze of shares
Thursday, 1 Sep 2016 02:00am EDT 

Winsan Shanghai Medical Science and Technology Co Ltd <600767.SS>: Says 4,247,317 shares and 49 million shares of the co held by a Shanghai-based investment group company were unfrozen by Shanghai branch of China Securities Depository and Clearing Co., Ltd .Says the Shanghai-based investment group company to transfer 53,508,343 shares (15.69 percent stake) of the co to a Sichuan-based asset management company.  Full Article

Winsan (Shanghai) Medical Science and Technology announces freezing of shares
Sunday, 3 Jul 2016 10:08pm EDT 

Winsan (Shanghai) Medical Science and Technology Co., Ltd. <600767.SS>:Says 53.5 million shares (15.7 pct stake) held by a Shanghai-based investment group will be frozen in order for three years.  Full Article

Winsan (Shanghai) Medical Science and Technology announces no dividend payment for 2015
Friday, 29 Apr 2016 08:00pm EDT 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:Says no dividend payment for 2015.  Full Article

Winsan (Shanghai) Medical Science and Technology to buy 10 pct stake in Shanghai-based financial information service company
Monday, 28 Mar 2016 08:00pm EDT 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:To buy 10 pct stake in Shanghai-based financial information service company from Guo Hong, for 29 mln yuan.  Full Article

Winsan (Shanghai) Medical Science and Technology announces freezing of shares
Monday, 1 Feb 2016 07:00pm EST 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:49 million shares (14.4 pct stake) held by a Shanghai-based investment company were frozen in order for three years.  Full Article

Winsan (Shanghai) Medical Science and Technology to buy 27.69 pct stake in Shanghai-based company
Thursday, 28 Jan 2016 07:00pm EST 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:To buy 27.69 pct stake in Shanghai-based information technology company, from another Shanghai-based company, for 29.50 mln yuan.To hold a 78.77 pct in the target company, after the transaction.  Full Article

Winsan (Shanghai) Medical Science and Technology announces private placement
Wednesday, 20 Jan 2016 07:00pm EST 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:To issue up to 25,853,200 A shares of its common stock through private placement, at no less than 16.90 yuan per share.To raise up to 436,919,100 yuan in total.The proceeds raised will be used for Internet healthy ecosystem construction and operation project.  Full Article

Winsan (Shanghai) Medical Science and Technology gives 2015 net profit outlook below I/B/E/S estimates
Monday, 18 Jan 2016 07:00pm EST 

Winsan (Shanghai) Medical Science and Technology Co., Ltd:Sees net profit for 2015 to be -43 mln yuan to -88 mln yuan.The net profit of 2014 was 25,983,746.46 yuan.2015 reported net profit of 62.54 million yuan – Thomson Reuters I/B/E/S.Comments that decreased sales income as the main reason for the forecast.  Full Article

More From Around the Web